LifeStance Expects Q1 Fiscal Year 2024 Revenues Of $287M-$307M, Versus Consensus Of $298.41M, With Center Margin Of $81M-$93M, And Adjusted EBITDA Of $17M-$23M
Portfolio Pulse from Benzinga Newsdesk
LifeStance Health Group, Inc. (LFST) forecasts Q1 FY2024 revenues to be between $287M-$307M, compared to the consensus estimate of $298.41M. The company also expects center margin to range from $81M-$93M and adjusted EBITDA to be between $17M-$23M.
February 28, 2024 | 11:16 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
LifeStance Health Group, Inc. (LFST) expects Q1 FY2024 revenues of $287M-$307M, center margin of $81M-$93M, and adjusted EBITDA of $17M-$23M.
LifeStance's revenue forecast aligns closely with consensus estimates, indicating a neutral short-term impact on its stock price. The provided ranges for center margin and adjusted EBITDA suggest operational stability, but without significantly exceeding expectations, the immediate impact on the stock price is likely neutral.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100